Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Secondary prevention with folic acid: results of the Goes extension study.

Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ.

Heart. 2005 Sep;91(9):1213-4. No abstract available.

PMID:
16103563
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Long-term follow-up of the West of Scotland Coronary Prevention Study].

Liakishev AA.

Kardiologiia. 2007;47(12):65-6. Russian. No abstract available.

PMID:
18260982
[PubMed - indexed for MEDLINE]
3.

Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.

Shojaei MH, Djalali M, Siassi F, Khatami MR, Boroumand MA, Eshragian MR.

Iran J Kidney Dis. 2009 Jul;3(3):141-4.

PMID:
19617662
[PubMed - indexed for MEDLINE]
Free Article
4.

Long-term follow-up of the West of Scotland Coronary Prevention Study.

DeFilippis AP, Bansal S, Blumenthal RS.

N Engl J Med. 2008 Jan 10;358(2):194; author reply 194-5. No abstract available.

PMID:
18193527
[PubMed - indexed for MEDLINE]
5.

Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).

Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D; TASPIC-CRO Study Group Investigators.

Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):646-54.

PMID:
16874158
[PubMed - indexed for MEDLINE]
6.

How effective is prevention in coronary heart disease?

Cupples ME, Smith SM, Murphy AW.

Heart. 2008 Nov;94(11):1370-1. doi: 10.1136/hrt.2007.133777. No abstract available.

PMID:
18931151
[PubMed - indexed for MEDLINE]
7.

[Reasons for the under-use of secondary prevention therapies in coronary patients over the age of 70 years].

Cournot M, Cambou JP, Quentzel S, Danchin N.

Ann Cardiol Angeiol (Paris). 2005 Dec;54 Suppl 1:S17-23. French.

PMID:
16411647
[PubMed - indexed for MEDLINE]
8.

Prognosis at 6 months for coronary and cerebrovascular patients: impact of antiplatelet agents and statins: results from the Prevenir III study.

Ferrières J, Cambou JP, Cantet C, Guize L.

Cardiovasc Drugs Ther. 2006 Feb;20(1):55-61.

PMID:
16552472
[PubMed - indexed for MEDLINE]
9.

Summaries for patients. The cost-effectiveness of aspirin, statins, or both drugs in the primary prevention of heart disease.

[No authors listed]

Ann Intern Med. 2006 Mar 7;144(5):I29. No abstract available.

PMID:
16520469
[PubMed - indexed for MEDLINE]
10.

Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.

Pahl E.

Pediatr Transplant. 2007 Aug;11(5):459-60. No abstract available.

PMID:
17631010
[PubMed - indexed for MEDLINE]
11.

Lipid-lowering therapy for elderly patients at risk for coronary events and stroke.

Courville KA, Lavie CJ, Milani RV.

Am Heart Hosp J. 2005 Fall;3(4):256-62. Review.

PMID:
16330918
[PubMed - indexed for MEDLINE]
12.

Continuation of statin treatment and all-cause mortality: a population-based cohort study.

Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD.

Arch Intern Med. 2009 Feb 9;169(3):260-8. doi: 10.1001/archinternmed.2008.552.

PMID:
19204217
[PubMed - indexed for MEDLINE]
13.

Long-term follow-up of the West of Scotland Coronary Prevention Study.

Tsubokura M, Kami M.

N Engl J Med. 2008 Jan 10;358(2):193-4; author reply 194-5. No abstract available.

PMID:
18193526
[PubMed - indexed for MEDLINE]
14.

Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.

Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P; USIC 2000 investigators.

Am Heart J. 2005 Dec;150(6):1147-53.

PMID:
16338251
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of statins added to aspirin therapy.

Chelmowski MK.

Ann Intern Med. 2006 Aug 1;145(3):233; author reply 233-4. No abstract available.

PMID:
16880474
[PubMed - indexed for MEDLINE]
16.

The polypill.

Drown DJ.

Prog Cardiovasc Nurs. 2003 Fall;18(4):197. No abstract available.

PMID:
14605522
[PubMed - indexed for MEDLINE]
17.
18.

Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike?

Maroo BP, Lavie CJ, Milani RV.

Drugs Aging. 2008;25(8):649-64. Review.

PMID:
18665658
[PubMed - indexed for MEDLINE]
19.

Polypill: for Pollyanna.

Spence JD.

Int J Stroke. 2008 May;3(2):92-7. doi: 10.1111/j.1747-4949.2008.00169.x. Review.

PMID:
18706002
[PubMed - indexed for MEDLINE]
20.

Are lipid-lowering guidelines evidence-based?

Abramson J, Wright JM.

Lancet. 2007 Jan 20;369(9557):168-9. No abstract available.

PMID:
17240267
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk